|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q4 FY2010
As of Dec 31, 2010
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Short-term bank deposits | ||||||||||||||||
| Marketable securities | ||||||||||||||||
| Trade receivables, net | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Total current assets | ||||||||||||||||
| LONG-TERM ASSETS: | ||||||||||||||||
| Marketable securities | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||
| Intangible assets, net | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Lease prepayment | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total long-term assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||
| Trade payables | ||||||||||||||||
| Employees and payroll accruals | ||||||||||||||||
| Deferred revenues | ||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| LONG-TERM LIABILITIES: | ||||||||||||||||
| Convertible senior notes, net | ||||||||||||||||
| Deferred revenues | ||||||||||||||||
| Income tax accrual | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Total long-term liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| SHAREHOLDERS' EQUITY: | ||||||||||||||||
| Ordinary shares, NIS 0.01 par value, 500,000,000 shares authorized at December 31, 2025 and 2024; 261,223,970 shares issued at December 31, 2025 and 2024; 105,596,035 and 108,368,523 shares outstanding at December 31, 2025 and 2024, respectively | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Treasury shares at cost, 155,627,935 and 152,855,447 ordinary shares at December 31, 2025 and 2024, respectively | ||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||
| Retained earnings | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...
